Clinical Trials · NCT07466498
Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Fred Hutchinson Cancer Center
- Enrollment
- 60
- Start date
- Nov 2026
- Locations
- 1 site, United States
- Primary endpoint
- Change in median daily hot flash score